Fulton Bank, N.A. Novartis Ag Transaction History

Fulton Bank, N.A.

$1.21 Billion
Q4 2024

A detailed history of Fulton Bank, N.A. transactions in Novartis Ag stock. As of the latest transaction made, Fulton Bank, N.A. holds 7,777 shares of NVS stock, worth $837,971. This represents 0.06% of its overall portfolio holdings.

Number of Shares

7,777

Previous 6,496 19.72%

Holding current value

$837,971

Previous $747,000 1.2%

% of portfolio

0.06%

Previous 0.06%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 08, 2025	BUY	$96.78 - $117.18 $123,975 - $150,107	1,281 Added 19.72%	7,777 $756,000
Q3 2024 Oct 07, 2024	BUY	$106.13 - $120.89 $28,336 - $32,277	267 Added 4.29%	6,496 $747,000
Q2 2024 Jul 09, 2024	SELL	$92.57 - $107.37 $79,332 - $92,016	-857 Reduced 12.09%	6,229 $663,000
Q1 2024 Apr 10, 2024	SELL	$95.27 - $108.47 $120,897 - $137,648	-1,269 Reduced 15.19%	7,086 $685,000
Q4 2023 Jan 04, 2024	BUY	$92.27 - $101.54 $74,185 - $81,638	804 Added 10.65%	8,355 $843,000
Q3 2023 Oct 04, 2023	BUY	$94.73 - $105.13 $96,245 - $106,812	1,016 Added 15.55%	7,551 $769,000
Q2 2023 Jul 06, 2023	BUY	$92.52 - $104.91 $39,228 - $44,481	424 Added 6.94%	6,535 $659,000
Q1 2023 Apr 06, 2023	SELL	$80.03 - $92.81 $70,106 - $81,301	-876 Reduced 12.54%	6,111 $562,000
Q4 2022 Jan 05, 2023	SELL	$75.55 - $92.52 $27,198 - $33,307	-360 Reduced 4.9%	6,987 $634,000
Q3 2022 Oct 04, 2022	SELL	$74.61 - $87.26 $273,147 - $319,458	-3,661 Reduced 33.26%	7,347 $559,000
Q2 2022 Jul 07, 2022	BUY	$80.52 - $93.75 $131,489 - $153,093	1,633 Added 17.42%	11,008 $931,000
Q1 2022 Apr 05, 2022	SELL	$80.11 - $90.62 $44,060 - $49,841	-550 Reduced 5.54%	9,375 $822,000
Q4 2021 Jan 05, 2022	SELL	$79.7 - $88.13 $339,282 - $375,169	-4,257 Reduced 30.02%	9,925 $868,000
Q3 2021 Oct 05, 2021	SELL	$81.78 - $95.14 $141,315 - $164,401	-1,728 Reduced 10.86%	14,182 $1.16 Million
Q2 2021 Jul 06, 2021	BUY	$85.24 - $94.15 $207,729 - $229,443	2,437 Added 18.09%	15,910 $1.45 Million
Q1 2021 Apr 05, 2021	BUY	$83.5 - $98.47 $263,860 - $311,165	3,160 Added 30.64%	13,473 $1.15 Million
Q4 2020 Jan 07, 2021	BUY	$78.07 - $94.43 $83,378 - $100,851	1,068 Added 11.55%	10,313 $974,000
Q3 2020 Oct 06, 2020	SELL	$82.14 - $91.0 $122,224 - $135,408	-1,488 Reduced 13.86%	9,245 $804,000
Q2 2020 Jul 06, 2020	BUY	$80.93 - $91.1 $389,597 - $438,555	4,814 Added 81.33%	10,733 $937,000
Q1 2020 Apr 03, 2020	BUY	$70.67 - $99.01 $193,141 - $270,594	2,733 Added 85.78%	5,919 $488,000
Q4 2019 Jan 24, 2020	BUY	$84.35 - $95.37 $22,774 - $25,749	270 Added 9.26%	3,186 $302,000
Q3 2019 Oct 03, 2019	BUY	$85.54 - $94.26 $53,291 - $58,723	623 Added 27.17%	2,916 $254,000
Q2 2019 Jul 03, 2019	SELL	$75.4 - $92.8 $156,455 - $192,560	-2,075 Reduced 47.5%	2,293 $210,000
Q1 2019 Apr 03, 2019	SELL	$75.32 - $86.15 $52,046 - $59,529	-691 Reduced 13.66%	4,368 $420,000
Q4 2018 Jan 03, 2019	BUY	$73.66 - $82.02 $111,226 - $123,850	1,510 Added 42.55%	5,059 $434,000
Q3 2018 Oct 03, 2018	SELL	$66.94 - $77.43 $30,390 - $35,153	-454 Reduced 11.34%	3,549 $306,000
Q2 2018 Jul 10, 2018	BUY	$64.91 - $73.36 $259,834 - $293,660	4,003 New	4,003 $302,000

Others Institutions Holding NVS

# of Institutions

1,444

Shares Held

132M

Call Options Held

1.12M

Put Options Held

1.61M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $232B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulton Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Fulton Bank, N.A. with notifications on news.

Account